Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Diverse histomorphology of HER2 positive breast carcinomas based on differential ER expression.

Akashi M, Yamaguchi R, Kusano H, Obara H, Yamaguchi M, Toh U, Akiba J, Kakuma T, Tanaka M, Akagi Y, Yano H.

Histopathology. 2019 Sep 25. doi: 10.1111/his.14003. [Epub ahead of print]

PMID:
31554015
2.

Gender differences in physical activity and sedentary behavior of Japanese primary school children during school cleaning time, morning recess and lunch recess.

Tanaka C, Tanaka M, Inoue S, Okuda M, Tanaka S.

BMC Public Health. 2019 Jul 23;19(1):985. doi: 10.1186/s12889-019-7256-5.

3.

Biological responses following one-stage full-mouth scaling and root planing with and without azithromycin: Multicenter randomized trial.

Yashima A, Morozumi T, Yoshie H, Hokari T, Izumi Y, Akizuki T, Mizutani K, Takamatsu H, Minabe M, Miyauchi S, Yoshino T, Tanaka M, Tanaka Y, Gomi K.

J Periodontal Res. 2019 Dec;54(6):709-719. doi: 10.1111/jre.12680. Epub 2019 Jul 10.

PMID:
31292965
4.

Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth.

Wu Z, Ichinose T, Naoe Y, Matsumura S, Villalobos IB, Eissa IR, Yamada S, Miyajima N, Morimoto D, Mukoyama N, Nishikawa Y, Koide Y, Kodera Y, Tanaka M, Kasuya H.

Mol Ther Oncolytics. 2019 May 13;13:107-115. doi: 10.1016/j.omto.2019.04.004. eCollection 2019 Jun 28.

5.

The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.

Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H.

Cancers (Basel). 2018 Sep 26;10(10). pii: E356. doi: 10.3390/cancers10100356. Review.

6.

Association between age at onset of independent walking and objectively measured sedentary behavior is mediated by moderate-to-vigorous physical activity in primary school children.

Aoyama T, Tanaka S, Tanaka M, Okuda M, Inoue S, Tanaka C.

PLoS One. 2018 Sep 18;13(9):e0204030. doi: 10.1371/journal.pone.0204030. eCollection 2018.

7.

Associations of Physical Activity and Sedentary Time in Primary School Children with Their Parental Behaviors and Supports.

Tanaka C, Okuda M, Tanaka M, Inoue S, Tanaka S.

Int J Environ Res Public Health. 2018 Sep 13;15(9). pii: E1995. doi: 10.3390/ijerph15091995.

8.

Objectively evaluated physical activity and sedentary time in primary school children by gender, grade and types of physical education lessons.

Tanaka C, Tanaka M, Tanaka S.

BMC Public Health. 2018 Aug 2;18(1):948. doi: 10.1186/s12889-018-5910-y.

9.

Variability in school children's activity occurs in the recess and before-school periods.

Suzuki I, Okuda M, Tanaka M, Inoue S, Tanaka S, Tanaka C.

Pediatr Int. 2018 Aug;60(8):727-734. doi: 10.1111/ped.13616.

PMID:
29892996
10.

Effects of Antimicrobial Photodynamic Therapy and Local Administration of Minocycline on Clinical, Microbiological, and Inflammatory Markers of Periodontal Pockets: A Pilot Study.

Hokari T, Morozumi T, Komatsu Y, Shimizu T, Yoshino T, Tanaka M, Tanaka Y, Nohno K, Kubota T, Yoshie H.

Int J Dent. 2018 Apr 5;2018:1748584. doi: 10.1155/2018/1748584. eCollection 2018.

11.

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer.

Hirooka Y, Kasuya H, Ishikawa T, Kawashima H, Ohno E, Villalobos IB, Naoe Y, Ichinose T, Koyama N, Tanaka M, Kodera Y, Goto H.

BMC Cancer. 2018 May 25;18(1):596. doi: 10.1186/s12885-018-4453-z.

12.

Changes in Weight, Sedentary Behaviour and Physical Activity during the School Year and Summer Vacation.

Tanaka C, Reilly JJ, Tanaka M, Tanaka S.

Int J Environ Res Public Health. 2018 May 4;15(5). pii: E915. doi: 10.3390/ijerph15050915.

13.

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group.

Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13.

PMID:
29146401
14.

Retrospective Proteomic Analysis of a Novel, Cancer Metastasis-Promoting RGD-Containing Peptide.

Tsuru M, Sata M, Tanaka M, Umeyama H, Kodera Y, Shiwa M, Aoyagi N, Yasuda K, Matsuoka K, Fukuda T, Yamana H, Nagata K.

Transl Oncol. 2017 Dec;10(6):998-1007. doi: 10.1016/j.tranon.2017.10.001. Epub 2017 Nov 2.

15.

Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials.

Eissa IR, Naoe Y, Bustos-Villalobos I, Ichinose T, Tanaka M, Zhiwen W, Mukoyama N, Morimoto T, Miyajima N, Hitoki H, Sumigama S, Aleksic B, Kodera Y, Kasuya H.

Front Oncol. 2017 Jul 14;7:149. doi: 10.3389/fonc.2017.00149. eCollection 2017. Review.

16.

Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.

Nishimura R, Toh U, Tanaka M, Saimura M, Okumura Y, Saito T, Tanaka T, Teraoka M, Shimada K, Katayama K, Koga T, Kurashita K, Hasegawa S, Todoroki H, Kai Y, Ohi Y, Toyoshima S, Arima N, Mitsuyama S, Tamura K.

Oncology. 2017;93(1):51-61. doi: 10.1159/000468521. Epub 2017 May 6.

PMID:
28478451
17.

Association between objectively evaluated physical activity and sedentary behavior and screen time in primary school children.

Tanaka C, Tanaka M, Okuda M, Inoue S, Aoyama T, Tanaka S.

BMC Res Notes. 2017 May 2;10(1):175. doi: 10.1186/s13104-017-2495-y.

18.

Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity.

Hotta Y, Kasuya H, Bustos I, Naoe Y, Ichinose T, Tanaka M, Kodera Y.

Oncolytic Virother. 2017 Mar 13;6:31-38. doi: 10.2147/OV.S127179. eCollection 2017.

19.

Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression.

Shibata T, Watari K, Izumi H, Kawahara A, Hattori S, Fukumitsu C, Murakami Y, Takahashi R, Toh U, Ito KI, Ohdo S, Tanaka M, Kage M, Kuwano M, Ono M.

Cancer Res. 2017 Jan 15;77(2):545-556. doi: 10.1158/0008-5472.CAN-16-1593. Epub 2016 Nov 22.

20.

Prevalence and risk factors for peri-implant diseases in Japanese adult dental patients.

Ogata Y, Nakayama Y, Tatsumi J, Kubota T, Sato S, Nishida T, Takeuchi Y, Onitsuka T, Sakagami R, Nozaki T, Murakami S, Matsubara N, Tanaka M, Yoshino T, Ota J, Nakagawa T, Ishihara Y, Ito T, Saito A, Yamaki K, Matsuzaki E, Hidaka T, Sasaki D, Yaegashi T, Yasuda T, Shibutani T, Noguchi K, Araki H, Ikumi N, Aoyama Y, Kogai H, Nemoto K, Deguchi S, Takiguchi T, Yamamoto M, Inokuchi K, Ito T, Kado T, Furuichi Y, Kanazashi M, Gomi K, Takagi Y, Kubokawa K, Yoshinari N, Hasegawa Y, Hirose T, Sase T, Arita H, Kodama T, Shin K, Izumi Y, Yoshie H.

J Oral Sci. 2017 Mar 31;59(1):1-11. doi: 10.2334/josnusd.16-0027. Epub 2016 Oct 7.

Supplemental Content

Loading ...
Support Center